Effects of smoking on hormones, brain, and behavior

Hormones, Brain and Behavior Online

Volumn , Issue , 2009, Pages 3337-3364

  Sidhartha, T ^a   Poland, R E ^b   Rao, U ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Texas Health Resources   (United States)

Author keywords

Addiction; Cortisol; Estrogen; Hormones; HPA; Insulin; Nicotine; Osteoporosis; Smoking; Thyroid

Indexed keywords

EID: 84884733894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008088783-8.00108-X     Document Type: Chapter

References (307)

1. Abel L.A., Friedman L., Jesberger J., Malki A., Meltzer H.Y. Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders. Biological Psychiatry 1991, 29:1063-1072.
2. AdinoffB., Kiser J.M., Martin P.R., Linnoila M. Response of dehydroepiandrosterone to corticotropin-releasing hormone stimulation in alcohol-dependent subjects. Biological Psychiatry 1996, 40:1305-1307.
3. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry 1993, 150:1856-1861.
4. al'Absi M., Hatsukami D., Davis G.L. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl) 2005, 181(1):107-117.
5. al'Absi M., Hatsukami D., Davis G.L., Wittmers L.E. Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug and Alcohol Dependence 2004, 73:267-278.
6. al'Absi M., Wittmers L.E., Erickson J., Hatsukami D., Crouse B. Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacology, Biochemistry, and Behavior 2003, 74:401-410.
7. Amering M., Bankier B., Berger P., Griengl H., Windhaber J., Katschnig H. Panic disorder and cigarette smoking behavior. Comprehensive Psychiatry 1999, 40:35-38.
8. Anda R.F., Williamson D.F., Escobedo L.G., Mast E.E., Giovino G.A., Remington P.L. Depression and the dynamics of smoking. A national perspective. Journal of the American Medical Association 1990, 264:1541-1545.
9. Asvold B.O., Bjoro T., Nilsen T.I., Vatten L.J. Tobacco smoking and thyroid function: A population-based study. Archives of Internal Medicine 2007, 167:1428-1432.
10. Attvall S., Fowelin J., Lager I., Von Schenck H., Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. Journal of Internal Medicine 1993, 233:327-332.
11. 3H] norepinephrine release from mouse hippocampal synaptosomes. Molecular Pharmacology 2006, 70:967-976.
12. Baheiraei A., Pocock N.A., Eisman J.A., Nguyen N.D., Nguyen T.V. Bone mineral density, body mass index and cigarette smoking among Iranian women: Implications for prevention. BMC Musculoskeletal Disorders 2005, 6:34.
13. Bailly D., Dewailly D., Beuscart R., et al. Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report. Hormone Research 1989, 31:72-75.
14. Bainbridge K.E., Sowers M., Lin X., Harlow S.D. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporosis International 2004, 15:439-446.
15. Baker N., Adler L.E., Franks R.D., et al. Neurophysiological assessment of sensory gating in psychiatric inpatients: Comparison between schizophrenia and other diagnoses. Biological Psychiatry 1987, 22:603-617.
16. Baker N.J., Staunton M., Adler L.E., et al. Sensory gating deficits in psychiatric inpatients: Relation to catecholamine metabolites in different diagnostic groups. Biological Psychiatry 1990, 27:519-528.
17. Bakhireva L.N., Barrett-Connor E., Kritz-Silverstein D., Morton D.J. Modifiable predictors of bone loss in older men: A prospective study. American Journal of Preventive Medicine 2004, 26:436-442.
18. Balfour D.J., Ridley D.L. The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction?. Pharmacology, Biochemistry, and Behavior 2000, 66:79-85.
19. Baron J.A. Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious. British Medical Bulletin 1996, 52:58-73.
20. Baron J.A., Comi R.J., Cryns V., Brinck-Johnsen T., Mercer N.G. The effect of cigarette smoking on adrenal cortical hormones. Journal of Pharmacology and Experimental Therapeutics 1995, 272:151-155.
21. Baulieu E.E., Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:4089-4091.
22. Benowitz N.L., Hansson A., Jacob P. Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension 2002, 39:1107-1112.
23. Benowitz N.L., Kuyt F., Jacob P. Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clinical Pharmacology and Therapeutics 1984, 36:74-81.
24. Bernstein L., Pike M.C., Lobo R.A., Depue R.H., Ross R.K., Henderson B.E. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. British Journal of Obstetrics and Gynaecology 1989, 96:92-96.
25. Bjornerem A., Straume B., Midtby M., et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: The Tromso Study. Journal of Clinical Endocrinology and Metabolism 2004, 89:6039-6047.
26. Board F., Persky H., Hamburg D.A. Psychological stress and endocrine functions; Blood levels of adrenocortical and thyroid hormones in acutely disturbed patients. Psychosomatic Medicine 1956, 18:324-333.
27. Bonde J.P., Storgaard L. How work-place conditions, environmental toxicants and lifestyle affect male reproductive function. International Journal of Andrology 2002, 25:262-268.
28. Booker T.K., Butt C.M., Wehner J.M., Heinemann S.F., Collins A.C. Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice. Pharmacology, Biochemistry, and Behavior 2007, 87:146-157.
29. Boudarene M., Legros J.J., Timsit-Berthier M. Study of the stress response: Role of anxiety, cortisol and DHEAs. L'Encephale 2002, 28:139-146.
30. Boyadjieva N.I., Sarkar D.K. The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sciences 1997, 61:PL59-PL66.
31. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Research and Treatment 2008, 109:67-75. Breast Cancer Family Registry.
32. Breslau N., Schultz L.R., Johnson E.O., Peterson E.L., Davis G.C. Smoking and the risk of suicidal behavior: A prospective study of a community sample. Archives of General Psychiatry 2005, 62:328-334.
33. Brioni J.D., O'Neill A.B., Kim D.J., Decker M.W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. European Journal of Pharmacology 1993, 238:1-8.
34. Broadbear J.H., Winger G., Woods J.H. Self-administration of fentanyl, cocaine and ketamine: Effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology 2004, 176:398-406.
35. Brook J.S., Cohen P., Brook D.W. Longitudinal study of co-occurring psychiatric disorders and substance use. Journal of the American Academy of Child and Adolescent Psychiatry 1998, 37:322-330.
36. Brown R.A., Kahler C.W., Zvolensky M.J., Lejuez C.W., Ramsey S.E. Anxiety sensitivity: Relationship to negative affects smoking and smoking cessation in smokers with past major depressive disorder. Addictive Behaviors 2001, 26:887-899.
37. Bufalo N.E., Leite J.L., Guilhen A.C., Morari E.C., Granja F., Assumpcao L.V., Ward L.S. Smoking and susceptibility to thyroid cancer: An inverse association with CYP1A1 allelic variants. Endocrine-Related Cancer 2006, 13:1185-1193.
38. Buisson B., Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4(beta)2 nicotinic acetylcholine receptor function. Journal of Neuroscience 2001, 21:1819-1829.
39. Burns L., Ashwell M., Berry J., et al. UK Food Standards Agency Optimal Nutrition Status Workshop: Environmental factors that affect bone health throughout life. British Journal of Nutrition 2003, 89:835-840.
40. Byrne B., Cunningham S., Igoe D., Conroy R., McKenna T.J. Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome. Acta Endocrinologica 1991, 124:370-374.
41. Byrne D.G., Mazanov J. Adolescent stress and future smoking behaviour: A prospective investigation. Journal of Psychosomatic Research 2003, 54:313-321.
42. Caggiula A.R., Donny E.C., Epstein L.H., et al. The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrinology 1998, 23:143-159.
43. Cam G.R., Bassett J.R., Cairncross K.D. The action of nicotine on the pituitary-adrenal cortical axis. Archives Internationales de Pharmacodynamie et de Therapie 1979, 237:49-66.
44. Cao W., Burkholder T., Wilkins L., Collins A.C. A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacology, Biochemistry, and Behavior 1993, 45:803-809.
45. Cardounel A., Regelson W., Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: Mechanism of action. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York) 1999, 222:145-149.
46. Cassidenti D.L., Vijod A.G., Vijod M.A., Stanczyk F.Z., Lobo R.A. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. American Journal of Obstetrics and Gynecology 1990, 163:1953-1960.
47. Annual smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 1997-2001. MMWR 2005, 54:625-628. CDC.
48. Celentano E., Galasso R., Berrino F., et al. Correlates of age at natural menopause in the cohorts of EPIC-Italy. Tumori 2003, 89:608-614.
49. Chanoine J.P., Toppet V., Bourdoux P., Spehl M., Delange F. Smoking during pregnancy: A significant cause of neonatal thyroid enlargement. British Journal of Obstetrics and Gynaecology 1991, 98:65-68.
50. Cheeta S., Irvine E.E., Kenny P.J., File S.E. The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology 2001, 155:78-85.
51. Chiodera P., Volpi R., Capretti L., et al. Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. Clinical Endocrinology 1997, 46:351-357.
52. Christensen S.B., Ericsson U.B., Janzon L., Tibblin S., Melander A. Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. Journal of Clinical Endocrinology and Metabolism 1984, 58:615-618.
53. Clark C., Haines M.M., Head J., et al. Psychological symptoms and physical health and health behaviours in adolescents: A prospective 2-year study in East London. Addiction (Abingdon) 2007, 102:126-135.
54. Clementz B.A., Geyer M.A., BraffD.L. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. American Journal of Psychiatry 1998, 155:1691-1694.
55. Cohen S., Lichtenstein E. Perceived stress, quitting smoking, and smoking relapse. Health Psychology 1990, 9:466-478.
56. Cooper B.R., Wang C.M., Cox R.F., Norton R., Shea V., Ferris R.M. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 1994, 11:133-141.
57. Corpechot C., Robel P., Axelson M., Sjovall J., Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proceedings of the National Academy of Sciences of the United States of America 1981, 78:4704-4707.
58. Court J., Spurden D., Lloyd S., et al. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: Alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry 1999, 73:1590-1597.
59. Covey L.S., Sullivan M.A., Johnston J.A., Glassman A.H., Robinson M.D., Adams D.P. Advances in non-nicotine pharmacotherapy for smoking cessation. Drugs 2000, 59:17-31.
60. Cui C., Booker T.K., Allen R.S., et al. The beta3 nicotinic receptor subunit: A component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. Journal of Neuroscience 2003, 23:11045-11053.
61. Curtis G.C., Abelson J.L., Gold P.W. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: Changes in panic disorder and effects of alprazolam treatment. Biological Psychiatry 1997, 41:76-85.
62. Curtis L., Buisson B., Bertrand S., Bertrand D. Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Molecular Pharmacology 2002, 61:127-135.
63. Czeisler C.A., Ede M.C., Regestein Q.R., Kisch E.S., Fang V.S., Ehrlich E.N. Episodic 24-hour cortisol secretory patterns in patients awaiting elective cardiac surgery. Journal of Clinical Endocrinology and Metabolism 1976, 42:273-283.
64. Dalack G.W., Becks L., Hill E., Pomerleau O.F., Meador-WoodruffJ.H. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 1999, 21:195-202.
65. Damaj M.I., Kao W., Martin B.R. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. Journal of Pharmacology and Experimental Therapeutics 2003, 307:526-534.
66. Dani J.A., Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology 2007, 47:699-729.
67. Daniel M., Martin A.D., Drinkwater D.T. Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcified Tissue International 1992, 50:300-305.
68. Davenport K.E., Houdi A.A., Van Loon G.R. Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brain. Neuroscience Letters 1990, 113:40-46.
69. del Arbol J.L., Munoz J.R., Ojeda L., et al. Plasma concentrations of beta-endorphin in smokers who consume different numbers of cigarettes per day. Pharmacology, Biochemistry, and Behavior 2000, 67:25-28.
70. Dixon L., MedoffD.R., Wohlheiter K., et al. Correlates of severity of smoking among persons with severe mental illness. American Journal on Addictions 2007, 16:101-110.
71. Djuric V.J., Dunn E., Overstreet D.H., Dragomir A., Steiner M. Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiology and Behavior 1999, 67:533-537.
72. Dozois D.N., Farrow J.A., Miser A. Smoking patterns and cessation motivations during adolescence. International Journal of the Addictions 1995, 30:1485-1498.
73. Edenberg H.J., Foroud T., Conneally P.M., et al. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 3, 5, 15, 16, 17, and 22. American Journal of Medical Genetics 1997, 74:238-246.
74. Egger P., Duggleby S., Hobbs R., Fall C., Cooper C. Cigarette smoking and bone mineral density in the elderly. Journal of Epidemiology and Community Health 1996, 50:47-50.
75. Eliasson B. Cigarette smoking and diabetes. Progress in Cardiovascular Diseases 2003, 45:405-413.
76. Eliasson B., Attvall S., Taskinen M.R., Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. European Journal of Clinical Investigation 1997, 27:450-456.
77. Eliava M., Yilmazer-Hanke D., Asan E. Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: Ultrastructural evidence for dopaminergic control of amygdaloid stress systems. Histochemistry and Cell Biology 2003, 120:183-197.
78. English K.M., Pugh P.J., Parry H., Scutt N.E., Channer K.S., Jones T.H. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clinical Science (Lond) 2001, 100:661-665.
79. Ericsson U.B., Lindgarde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. Journal of Internal Medicine 1991, 229:67-71.
80. Facchini F.S., Hollenbeck C.B., Jeppesen J., Chen Y.D., Reaven G.M. Insulin resistance and cigarette smoking. Lancet 1992, 339:1128-1130.
81. Fagerstrom K.O., Heatherton T.F., Kozlowski L.T. Nicotine addiction and its assessment. Ear, Nose, and Throat Journal 1990, 69:763-765.
82. Fallon J.H., Koziell D.A., Moore R.Y. Catecholamine innervation of the basal forebrain II: Amygdala, suprarhinal cortex, and entorhinal cortex. Journal of Comparative Neurology 1978, 180(3):509-532.
83. Feldman H.A., Johannes C.B., McKinlay J.B., Longcope C. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: Cross-sectional results from the Massachusetts male aging study. Annals of Epidemiology 1998, 8:217-228.
84. Field A.E., Colditz G.A., Willett W.C., Longcope C., McKinlay J.B. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. Journal of Clinical Endocrinology and Metabolism 1994, 79:1310-1316.
85. Fisher C.L., Mannino D.M., Herman W.H., Frumkin H. Cigarette smoking and thyroid hormone levels in males. International Journal of Epidemiology 1997, 26:972-977.
86. Forsen L., Bjorndal A., Bjartveit K., Edna T.H., Holmen J., Jessen V., Westburg G. Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fracture. Journal of Bone and Mineral Research 1994, 9:1671-1678.
87. Frati A.C., Iniestra F., Ariza C.R. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996, 19:112-118.
88. Frederick S.L., Reus V.I., Ginsberg D., Hall S.M., Munoz R.F., Ellman G. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biological Psychiatry 1998, 43:525-530.
89. Freedman R., Adler L.E., Bickford P., et al. Schizophrenia and nicotinic receptors. Harvard Review of Psychiatry 1994, 2:179-192.
90. Freedman R., Coon H., Myles-Worsley M., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:587-592.
91. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biological Psychiatry 1995, 38:22-33.
92. Fryer J.D., Lukas R.J. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. Journal of Neurochemistry 1999, 72:1117-1124.
93. Fryer J.D., Lukas R.J. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. Journal of Pharmacology and Experimental Therapeutics 1999, 288:88-92.
94. Fukayama H., Nasu M., Murakami S., Sugawara M. Examination of antithyroid effects of smoking products in cultured thyroid follicles: Only thiocyanate is a potent antithyroid agent. Acta Endocrinologica 1992, 127:520-525.
95. Fuxe K., Andersson K., Eneroth P., Harfstrand A., Agnati L.F. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications. Psychoneuroendocrinology 1989, 14:19-41.
96. Galanti M.R., Granath F., Cnattingius S., Ekbom-Schnell A., Ekbom A. Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women. Journal of Internal Medicine 2005, 258:257-264.
97. Gallicchio L., Miller S.R., Visvanathan K., Lewis L.M., Babus J., Zacur H., Flaws J. Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas 2006, 53:133-143.
98. Gasparoni A., Autelli M., Ravagni-Probizer M.F., Bartoli A., Regazzi-Bonora M., Chirico G., Rondini G. Effect of passive smoking on thyroid function in infants. European Journal of Endocrinology 1998, 138:379-382.
99. Gerdhem P., Obrant K.J. Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound. Osteoporosis International 2002, 13:932-936.
100. Giannakoulas G., Katramados A., Melas N., Diamantopoulos I., Chimonas E. Acute effects of nicotine withdrawal syndrome in pilots during flight. Aviation, Space, and Environmental Medicine 2003, 74:247-251.
101. Gilbert D.G., Meliska C.J., Williams C.L., Jensen R.A. Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology 1992, 106:275-281.
102. Gilbert D.G., Robinson J.H., Chamberlin C.L., Spielberger C.D. Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie. Psychophysiology 1989, 26:311-320.
103. Ginns E.I., Ott J., Egeland J.A., et al. A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish. Nature Genetics 1996, 12:431-435.
104. Glassman A.H. Cigarette smoking: Implications for psychiatric illness. American Journal of Psychiatry 1993, 150:546-553.
105. Glassman A.H., Covey L.S., Dalack G.W., Stetner F., Rivelli S.K., Fleiss J., Cooper T.B. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacology and Therapeutics 1993, 54:670-679.
106. Glassman A.H., Covey L.S., Stetner F., Rivelli S. Smoking cessation and the course of major depression: A follow-up study. Lancet 2001, 357:1929-1932.
107. Gocze P.M., Freeman D.A. Cytotoxic effects of cigarette smoke alkaloids inhibit the progesterone production and cell growth of cultured MA-10 Leydig tumor cells. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2000, 93:77-83.
108. Gocze P.M., Szabo I., Freeman D.A. Influence of nicotine, cotinine, anabasine and cigarette smoke extract on human granulosa cell progesterone and estradiol synthesis. Gynecological Endocrinology 1999, 13:266-272.
109. Goeders N.E. Stress and cocaine addiction. Journal of Pharmacology and Experimental Therapeutics 2002, 301:785-789.
110. Goeders N.E., Clampitt D.M. Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. Psychopharmacology 2002, 161:222-232.
111. Goeders N.E., Guerin G.F. Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Research 1996, 722:145-152.
112. Goeders N.E., Guerin G.F. Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology 1996, 64:337-348.
113. Goeders N.E., Peltier R.L., Guerin G.F. Ketoconazole reduces low dose cocaine self-administration in rats. Drug and Alcohol Dependence 1998, 53:67-77.
114. Goenjian A.K., Pynoos R.S., Steinberg A.M., Endres D., Abraham K., Geffner M.E., Fairbanks D.C. Hypothalamic-pituitary-adrenal activity among Armenian adolescents with PTSD symptoms. Journal of Traumatic Stress 2003, 16:319-323.
115. Goff, Henderson D.C., Amico E. Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992, 149:1189-1194.
116. Gorelick D.A., Rose J., Jarvik M.E. Effect of naloxone on cigarette smoking. Journal of Substance Abuse 1988, 1:153-159.
117. Gossain V.V., Sherma N.K., Srivastava L., Michelakis A.M., Rovner D.R. Hormonal effects of smoking. II: Effects on plasma cortisol, growth hormone, and prolactin. American Journal of the Medical Sciences 1986, 291:325-327.
118. Greaves-Lord K., Ferdinand R.F., Oldehinkel A.J., Sondeijker F.E., Ormel J., Verhulst F.C. Higher cortisol awakening response in young adolescents with persistent anxiety problems. Acta Psychiatrica Scandinavica 2007, 116:137-144.
119. Grun E.U., Pauly J.R., Bullock A.E., Collins A.C. Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity. Pharmacology, Biochemistry, and Behavior 1995, 52:629-635.
120. Gu X.L., Mao J.Y., Shan Z.Y., et al. Epidemiological study of the effects of smoking cigarette on thyroid gland. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi 2007, 28:53-56.
121. Guignard R., Truong T., Rougier Y., Baron-Dubourdieu D., Guenel P. Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: A countrywide case-control study in New Caledonia. American Journal of Epidemiology 2007, 166:1140-1149.
122. Handa K., Kono S., Ishii H., Shinchi K., Imanishi K., Arakawa K. Relationship of alcohol consumption and smoking to plasma cortisol and blood pressure. Journal of Human Hypertension 1994, 8:891-894.
123. Harlow B.L., Signorello L.B. Factors associated with early menopause. Maturitas 2000, 35:3-9.
124. Harrison P.J. The neuropathology of primary mood disorder. Brain 2002, 125:1428-1449.
125. Hautanen A., Manttari M., Kupari M., Sarna S., Manninen V., Frick M.H., Adlercreutz H. Cigarette smoking is associated with elevated adrenal androgen response to adrenocorticotropin. Journal of Steroid Biochemistry and Molecular Biology 1993, 46:245-251.
126. Hegedus L., Karstrup S., Veiergang D., Jacobsen B., Skovsted L., Feldt-Rasmussen U. High frequency of goitre in cigarette smokers. Clinical Endocrinology 1985, 22:287-292.
127. Helve E., Yki-Jarvinen H., Koivisto V.A. Smoking and insulin sensitivity in type I diabetic patients. Metabolism: Clinical and Experimental 1986, 35:874-877.
128. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Frontiers in Neuroendocrinology 2003, 24:151-180.
129. Hirshman E., Wells E., Wierman M.E., Anderson B., Butler A., Senholzi M., Fisher J. The effect of dehydroepiandrosterone (DHEA) on recognition memory decision processes and discrimination in postmenopausal women. Psychonomic Bulletin and Review 2003, 10:125-134.
130. Hornsby P.P., Wilcox A.J., Weinberg C.R. Cigarette smoking and disturbance of menstrual function. Epidemiology (Cambridge, MA) 1998, 9:193-198.
131. Hughes E.G., Brennan B.G. Does cigarette smoking impair natural or assisted fecundity?. Fertility and Sterility 1996, 66:679-689.
132. Hughes J.R., Arana G., Amori G., Stewart F., Workman R. Effect of tobacco withdrawal on the dexamethasone suppression test. Biological Psychiatry 1988, 23:96-98.
133. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 1986, 143:993-997.
134. Hughes J.R., Stead L.F., Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, 3. CD000031. 10.1002/14651858.
135. Iancu I., Tchernihovsky E., Maayan R., et al. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients. European Neuropsychopharmacology 2007, 17:541-545.
136. Irvine E.E., Cheeta S., Marshall M., File S.E. Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects. Pharmacology, Biochemistry, and Behavior 2001, 68:769-776.
137. Izumotani K., Hagiwara S., Izumotani T., Miki T., Morii H., Nishizawa Y. Risk factors for osteoporosis in men. Journal of Bone and Mineral Metabolism 2003, 21:86-90.
138. Jakovljevic M., Muck-Seler D., Pivac N., Crncevic Z. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia. Neuropsychobiology 1998, 37:142-145.
139. Janowsky D., Overstreet D. The role of acetylcholine mechanisms in mood disorders. Psychopharmacology: The Fourth Generation of Progress 1995, 945-956. Raven Press, New York. F. Bloom, D. Kupfer (Eds.).
140. Janowsky D.S., el-Yousef M.K., Davis J.M., Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972, 2:632-635.
141. Janowsky D.S., Overstreet D.H., Nurnberger J.I. Is cholinergic sensitivity a genetic marker for the affective disorders?. American Journal of Medical Genetics 1994, 54:335-344.
142. Janowsky D.S., Risch S.C. Cholinomimetic and anticholinergic drugs used to investigate an acetylcholine hypothesis of affective disorders and stress. Drug Development Research 1984, 4:125-142.
143. Jansen L.M., Gispen-de Wied C.C., Gademan P.J., De Jonge R.C., van der Linden J.A., Kahn R.S. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophrenia Research 1998, 33:87-94.
144. Jansen L.M., Gispen-de Wied C.C., Kahn R.S. Selective impairments in the stress response in schizophrenic patients. Psychopharmacology 2000, 149:319-325.
145. Jensen G.F. Osteoporosis of the slender smoker revisited by epidemiologic approach. European Journal of Clinical Investigation 1986, 16:239-242.
146. Jensen T.K., Henriksen T.B., Hjollund N.H., et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. American Journal of Epidemiology 1998, 148:992-997.
147. Jones G., Scott F.S. A cross-sectional study of smoking and bone mineral density in premenopausal parous women: Effect of body mass index, breastfeeding, and sports participation. Journal of Bone and Mineral Research 1999, 14:1628-1633.
148. Jorenby D.E., Hatsukami D.K., Smith S.S., Fiore M.C., Allen S., Jensen J., Timorthy B.B. Characterization of tobacco withdrawal symptoms: Transdermal nicotine reduces hunger and weight gain. Psychopharmacology 1996, 128:130-138.
149. Juchau M.R., Namkung J., Chao S.T. Mono-oxygenase induction in the human placenta. Interrelationships among position-specific hydroxylations of 17 beta-estradiol and benzo[a]pyrene. Drug Metabolism and Disposition: The Biological Fate of Chemicals 1982, 10:220-224.
150. Kagan J., Reznick J.S., Snidman N. The physiology and psychology of behavioral inhibition in children. Child Development 1987, 58:1459-1473.
151. Karakaya A., Tuncel N., Alptuna G., Kocer Z., Erbay G. Influence of cigarette smoking on thyroid hormone levels. Human Toxicology 1987, 6:507-509.
152. Kathmann N., Hochrein A., Uwer R., Bondy B. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. American Journal of Psychiatry 2003, 160:696-702.
153. Kendler K.S., Neale M.C., MacLean C.J., Heath A.C., Eaves L.J., Kessler R.C. Smoking and major depression. A causal analysis. Archives of General Psychiatry 1993, 50:36-43.
154. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:1852-1857.
155. Kimonides V.G., Spillantini M.G., Sofroniew M.V., Fawcett J.W., Herbert J. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 1999, 89:429-436.
156. Kirschbaum C., Scherer G., Strasburger C.J. Pituitary and adrenal hormone responses to pharmacological, physical, and psychological stimulation in habitual smokers and nonsmokers. Clinical Investigator 1994, 72:804-810.
157. Kirschbaum C., Strasburger C.J., Langkrar J. Attenuated cortisol response to psychological stress but not to CRH or ergometry in young habitual smokers. Pharmacology, Biochemistry, and Behavior 1993, 44:527-531.
158. Kirschbaum C., Wust S., Strasburger C.J. Normal' cigarette smoking increases free cortisol in habitual smokers. Life Sciences 1992, 50:435-442.
159. Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. American Journal of Psychiatry 2007, 164:1149-1159.
160. Koval J.J., Pederson L.L., Mills C.A., McGrady G.A., Carvajal S.C. Models of the relationship of stress, depression, and other psychosocial factors to smoking behavior: A comparison of a cohort of students in grades 6 and 8. Preventive Medicine 2000, 30:463-477.
161. Krassas G.E., Wiersinga W. Smoking and autoimmune thyroid disease: The plot thickens. European Journal of Endocrinology 2006, 154:777-780.
162. Kroboth P.D., Salek F.S., Pittenger A.L., Fabian T.J., Frye R.F. DHEA and DHEA-S: A review. Journal of Clinical Pharmacology 1999, 39:327-348.
163. Labarca C., Schwarz J., Deshpande P., et al. Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2786-2791.
164. Lai I.C., Hong C.J., Tsai S.J. Association study of nicotinic-receptor
165. Lapchak P.A., Araujo D.M. Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. International Review of Neurobiology 2001, 46:379-397.
166. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association 2000, 284:2606-2610.
167. Law M.R., Cheng R., Hackshaw A.K., Allaway S., Hale A.K. Cigarette smoking, sex hormones and bone density in women. European Journal of Epidemiology 1997, 13:553-558.
168. Lazarus R.S., Folkman S. Stress, Appraisal and Coping 1984, Springer, New York.
169. LeDoux J.E. Emotional memory systems in the brain. Behavioural Brain Research 1993, 58:69-79.
170. Leonard S., Adler L.E., Benhammou K., et al. Smoking and mental illness. Pharmacology, Biochemistry, and Behavior 2001, 70:561-570.
171. Leonard S., Gault J., Hopkins J., et al. Association of promoter variants in the alpha 7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Archives of General Psychiatry 2002, 59(12):1085-1096.
172. Leonard S., Gault J., Moore T., et al. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative. American Journal of Medical Genetics 1998, 81:308-312.
173. Linkowski P., Van Onderbergen A., Kerkhofs M., Bosson D., Mendlewicz J., Van Cauter E. Twin study of the 24-h cortisol profile: Evidence for genetic control of the human circadian clock. American Journal of Physiology 1993, 264:E173-E181.
174. Lofroth G. Environmental tobacco smoke: Overview of chemical composition and genotoxic components. Mutation Research 1989, 222:73-80.
175. Lovallo W.R. Cortisol secretion patterns in addiction and addiction risk. International Journal of Psychophysiology 2006, 59:195-202.
176. Lovallo W.R., Dickensheets S.L., Myers D.A., Thomas T.L., Nixon S.J. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcoholism, Clinical and Experimental Research 2000, 24:651-658.
177. MacInnis R.J., Cassar C., Nowson C.A., et al. Determinants of bone density in 30-to 65-year-old women: A co-twin study. Journal of Bone and Mineral Research 2003, 18:1650-1656.
178. Mack W.J., Preston-Martin S., Dal Maso L., et al. A pooled analysis of case-control studies of thyroid cancer: Cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 2003, 14:773-785.
179. MacMahon B., Trichopoulos D., Cole P., Brown J. Cigarette smoking and urinary estrogens. New England Journal of Medicine 1982, 307:1062-1065.
180. Madsbad S., McNair P., Christensen M.S., Christiansen C., Faber O.K., Binder C., Transbol I. Influence of smoking on insulin requirement and metbolic status in diabetes mellitus. Diabetes Care 1980, 3:41-43.
181. Mahlberg R., Steinacher B., Mackert A., Flechtner K.M. Basic parameters of saccadic eye movements: Differences between unmedicated schizophrenia and affective disorder patients. European Archives of Psychiatry and Clinical Neuroscience 2001, 251:205-210.
182. Malin D.H., Lake J.R., Upchurch T.P., Shenoi M., Rajan N., Schweinle W.E. Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine. Pharmacology, Biochemistry, and Behavior 1998, 60:609-613.
183. Malone K.M., Waternaux C., Haas G.L., Cooper T.B., Li S., Mann J.J. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. American Journal of Psychiatry 2003, 160:773-779.
184. Manson J.E., Ajani U.A., Liu S., Nathan D.M., Hennekens C.H. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. American Journal of Medicine 2000, 109:538-542.
185. Martel F.L., Hayward C., Lyons D.M., Sanborn K., Varady S., Schatzberg A.F. Salivary cortisol levels in socially phobic adolescent girls. Depression and Anxiety 1999, 10:25-27.
186. Marty M.A., Erwin V.G., Cornell K., Zgombick J.M. Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro. Pharmacology, Biochemistry, and Behavior 1985, 22:317-325.
187. Marutle A., Zhang X., Court J., Piggott M., Johnson M., Perry R., Nordberg A. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. Journal of Chemical Neuroanatomy 2001, 22:115-126.
188. Marx C.E., Trost W.T., Shampine L., Behm F.M., Giordano L.A., Massing M.W., Rose J.E. Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology 2006, 186:462-472.
189. Matta S.G., Beyer H.S., McAllen K.M., Sharp B.M. Nicotine elevates rat plasma ACTH by a central mechanism. Journal of Pharmacology and Experimental Therapeutics 1987, 243:217-226.
190. Matta S.G., Fu Y., Valentine J.D., Sharp B.M. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998, 23:103-113.
191. Matta S.G., McCoy J.G., Foster C.A., Sharp B.M. Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion in the hypothalamic paraventricular nucleus: An in vivo microdialysis study. Neuroendocrinology 1995, 61:383-392.
192. Mazess R.B., Barden H.S. Bone density in premenopausal women: Effects of age, dietary intake, physical activity, smoking, and birth-control pills. American Journal of Clinical Nutrition 1991, 53:132-142.
193. McCabe R.E., Chudzik S.M., Antony M.M., Young L., Swinson R.P., Zolvensky M.J. Smoking behaviors across anxiety disorders. Journal of Anxiety Disorders 2004, 18:7-18.
194. McCulloch P., Lee S., Higgins R., McCall K., Schade D.S. Effect of smoking on hemoglobin A1c and body mass index in patients with type 2 diabetes mellitus. Journal of Investigative Medicine 2002, 50:284-287.
195. McEvoy J.P., Freudenreich O., Wilson W.H. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry 1999, 46:125-129.
196. McGinnis J.M., Foege W.H. Actual causes of death in the United States. Journal of the American Medical Association 1993, 270:2207-2212.
197. Meberg A., Marstein S. Smoking during pregnancy: Effects on the fetal thyroid function. Acta Paediatrica Scandinavica 1986, 75:762-766.
198. Mendelson J.H., Goletiani N., Sholar M.B., Siegel A.J., Mello N.K. Effects of low- and high-nicotine cigarette smoking on mood states and HPA axis in men. Neuropsychopharmacology 2005, 30(9):1751-1763.
199. Mendelson J.H., Goletiani N., Sholar M.B., Siegel A.J., Mello N.K. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 2008, 33:749-760.
200. Michnovicz J.J., Hershcopf R.J., Naganuma H., Bradlow H.L., Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New England Journal of Medicine 1986, 315:1305-1309.
201. Mueck A.O., Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Arzneimittel-Forschung 2003, 53:1-11.
202. Muller B., Zulewski H., Huber P., Ratcliffe J.G., Staub J.J. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. New England Journal of Medicine 1995, 333:964-969.
203. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Reviews 1984, 5:25-44.
204. Nagamoto H.T., Adler L.E., McRae K.A., et al. Auditory P50 in schizophrenics on clozapine: Improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol. Neuropsychobiology 1999, 39:10-17.
205. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nature Reviews 2001, 2:119-128.
206. Newhouse P.A., Sunderland T., Narang P.K., Mellow A.M., Fertig J.B., Lawlor B.A., Murphy D.L. Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease. Psychoneuroendocrinology 1990, 15:471-484.
207. Nguyen T.V., Kelly P.J., Sambrook P.N., Gilbert C., Pocock N.A., Eisman J.A. Lifestyle factors and bone density in the elderly: Implications for osteoporosis prevention. Journal of Bone and Mineral Research 1994, 9:1339-1346.
208. Nichter M., Nichter M., Vuckovic N., Quintero G., Ritenbaugh C. Smoking experimentation and initiation among adolescent girls: Qualitative and quantitative findings. Tobacco Control 1997, 6:285-295.
209. Nisell M., Nomikos G.G., Svensson T.H. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacology and Toxicology 1995, 76:157-162.
210. Nuechterlein K.H., Dawson M.E., Ventura J., et al. The vulnerability/stress model of schizophrenic relapse: A longitudinal study. Acta Psychiatrica Scandinavica 1994, 89(supplement 382):58-64.
211. Nystrom E., Bengtsson C., Lapidus L., Petersen K., Lindstedt G. Smoking - a risk factor for hypothyroidism. Journal of Endocrinological Investigation 1993, 16:129-131.
212. Olincy A., Stevens K.E. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochemical Pharmacology 2007, 74:1192-1201.
213. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997, 42:1-5.
214. Oncken C., Prestwood K., Cooney J.L., Unson C., Fall P., KulldorffM., Raisz L.G. Effects of smoking cessation or reduction on hormone profiles and bone turnover in postmenopausal women. Nicotine and Tobacco Research 2002, 4:451-458.
215. Orlando M., Ellickson P.L., Jinnett K. The temporal relationship between emotional distress and cigarette smoking during adolescence and young adulthood. Journal of Consulting and Clinical Psychology 2001, 69:959-970.
216. Owens J.C., Balogh S.A., McClure-Begley T.D., et al. Alpha 4 beta 2* nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. Alcoholism: Clinical and Experimental Research 2003, 27(12):1867-1875.
217. Pacak K., Palkovits M., Kvetnansky R., Yadid G., Kopin I.J., Goldstein D.S. Effects of various stressors on in vivo norepinephrine release in the hypothalamic paraventricular nucleus and on the pituitary-adrenocortical axis. Annals of the New York Academy of Sciences 1995, 771:115-130.
218. Pauly J.R., Grun E.U., Collins A.C. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice. Psychopharmacology 1990, 101:310-316.
219. Pauly J.R., Ullman E.A., Collins A.C. Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiology and Behavior 1988, 44:109-116.
220. Pauly J.R., Ullman E.A., Collins A.C. Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse. Pharmacology, Biochemistry, and Behavior 1990, 35:171-179.
221. Petrusz P., Merchenthaler I., Maderdrut J.L., Heitz P.U. Central and peripheral distribution of corticotropin-releasing factor. Federation Proceedings 1985, 44:229-235.
222. Pickworth W.B., Baumann M.H., Fant R.V., Rothman R.B., Henningfield J.E. Endocrine responses during acute nicotine withdrawal. Pharmacology, Biochemistry, and Behavior 1996, 55:433-437.
223. Pomerleau C.S., Marks J.L., Pomerleau O.F. Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology. Nicotine and Tobacco Research 2000, 2:275-280.
224. Pomerleau O.F. Nicotine and the central nervous system: Biobehavioral effects of cigarette smoking. American Journal of Medicine 1992, 93:2S-7S.
225. Pomerleau O.F., Pomerleau C.S. Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation. Neuroscience and Biobehavioral Reviews 1984, 8:503-513.
226. Pomerleau O.F., Pomerleau C.S., Snedecor S.M., Gaulrapp S., Brouwer R.N., Cameron O.G. Depression, smoking abstinence and HPA function in women smokers. Human Psychopharmacology 2004, 19:467-476.
227. Pomerleau O.F., Rosecrans J. Neuroregulatory effects of nicotine. Psychoneuroendocrinology 1989, 14:407-423.
228. Prummel M.F., Wiersinga W.M. Smoking and risk of Graves' disease. Journal of the American Medical Association 1993, 269:479-482.
229. Rasmussen D.D. Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation. Psychoneuroendocrinology 1998, 23:245-259.
230. Rasmusson A.M., Wu R., Paliwal P., Anderson G.M., Krishnan-Sarin S. A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: A preliminary study. Psychopharmacology 2006, 186:473-480.
231. Rao U., Hammen C., London E.D., Poland R.E. Vulnerability for cigarette smoking in adolescents: A diathesis-stress model 2007.
232. Raux G., Bonnet-Brilhault F., Louchart S., et al. The 2-bp deletion in exon 6 of the alpha 7-like nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit. Molecular Psychiatry 2002, 7(9):1006-1011.
233. Reeves G.K., Pirie K., Beral V., Green J., Spencer E., Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. British Medical Journal 2007, 333. 10.1136/bmj.39367.495995.AE.
234. Rhodes M.E., Kennell J.S., Belz E.E., Czambel R.K., Rubin R.T. Rat estrous cycle influences the sexual diergism of HPA axis stimulation by nicotine. Brain Research Bulletin 2004, 64:205-213.
235. Rhodes M.E., O'Toole S.M., Czambel R.K., Rubin R.T. Male-female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation. Brain Research Bulletin 2001, 54:681-688.
236. Rimm E.B., Manson J.E., Stampfer M.J., et al. Cigarette smoking and the risk of diabetes in women. American Journal of Public Health 1993, 83:211-214.
237. Rimondini R., Arlinde C., Sommer W., Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB Journal 2002, 16:27-35.
238. Ritsner M., Gibel A., Maayan R., et al. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology 2005, 30:1913-1922.
239. Ritsner M., Gibel A., Maayan R., Ratner Y., Ram E., Modai I., Weizman A. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients. European Neuropsychopharmacology 2007, 17:257-264.
240. Ritsner M., Maayan R., Gibel A., Strous R.D., Modai I., Weizman A. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. European Neuropsychopharmacology 2004, 14:267-273.
241. Rodriguez de Fonseca F., Carrera M.R., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (New York) 1997, 276:2050-2054.
242. Rohleder N., Kirschbaum C. The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. International Journal of Psychophysiology 2006, 59:236-243.
243. Rolls E.T., Stringer S.M. A model of the interaction between mood and memory. Network (Bristol) 2001, 12:89-109.
244. Rose J.E., Ananda S., Jarvik M.E. Cigarette smoking during anxiety-provoking and monotonous tasks. Addictive Behaviors 1983, 8:353-359.
245. Rosecrans J.A., Karin L.D. Effects of nicotine on the hypothalamic-pituitary-axis (HPA) and immune function: Introduction to the sixth nicotine round table satellite, American society of addiction medicine nicotine dependence meeting, November 15, 1997. Psychoneuroendocrinology 1998, 23:95-102.
246. Rosenberg M.J., Waugh M.S., Stevens C.M. Smoking and cycle control among oral contraceptive users. American Journal of Obstetrics and Gynecology 1996, 174:628-632.
247. Ross R.G., Olincy A., Mikulich S.K., et al. Admixture analysis of smooth pursuit eye movements in probands with schizophrenia and their relatives suggests gain and leading saccades are potential endophenotypes. Psychophysiology 2002, 39(6):809-819.
248. Ross S.A., Wong J.Y., Clifford J.J., et al. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. Journal of Neuroscience 2000, 20:6431-6441.
249. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003, 37:577-582.
250. Salas R., Pieri F., Fung B., Dani J.A., De Biasi M. Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. Journal of Neuroscience 2003, 23:6255-6263.
251. Salin-Pascual R.J., Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. Neuro Report 1998, 9:57-60.
252. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Distribution of corticosteroid receptors in the rhesus brain: Relative absence of glucocorticoid receptors in the hippocampal formation. Journal of Neuroscience 2000, 20:4657-4668.
253. Sargeant L.A., Khaw K.T., Bingham S., et al. Cigarette smoking and glycaemia: The EPIC-Norfolk Study. European prospective investigation into cancer. International Journal of Epidemiology 2001, 30:547-554.
254. Schindler A.E. Climacteric symptoms and hormones. Gynecological Endocrinology 2006, 22:151-154.
255. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., Krieg J.C. Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology 1996, 15:7-15.
256. Seyler L.E., Pomerleau O.F., Fertig J.B., Hunt D., Parker K. Pituitary hormone response to cigarette smoking. Pharmacology, Biochemistry, and Behavior 1986, 24:159-162.
257. Sharp B.M., Beyer H.S. Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. Journal of Pharmacology and Experimental Therapeutics 1986, 238:486-491.
258. Sharp B.M., Matta S.G. Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: Dose-dependency and desensitization. Endocrinology 1993, 133:11-19.
259. Shine B., Fells P., Edwards O.M., Weetman A.P. Association between Graves' ophthalmopathy and smoking. Lancet 1990, 335:1261-1263.
260. Shirazi-Southall S., Rodriguez D.E., Nomikos G.G. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 2002, 26:583-594.
261. Shiverick K.T., Salafia C. Cigarette smoking and pregnancy I: Ovarian, uterine and placental effects. Placenta 1999, 20:265-272.
262. Shytle R.D., Silver A.A., Lukas R.J., Newman M.B., Sheehan D.V., Sanberg P.R. Nicotinic acetylcholine receptors as targets for antidepressants. Molecular Psychiatry 2002, 7:525-535.
263. Siqueira L., Diab M., Bodian C., Rolnitzky L. Adolescents becoming smokers: The roles of stress and coping methods. Journal of Adolescent Health 2000, 27:399-408.
264. Sirola J., Kroger H., Honkanen R., Sandini L., Tuppurainen M., Jurvelin J.S., Saarikoski S. Smoking may impair the bone protective effects of nutritional calcium: A population-based approach. Journal of Bone and Mineral Research 2003, 18:1036-1042.
265. Slemenda C.W., Christian J.C., Reed T., Reister T.K., Williams C.J., Johnston C.C. Long-term bone loss in men: Effects of genetic and environmental factors. Annals of Internal Medicine 1992, 117:286-291.
266. Slemmer J.E., Martin B.R., Damaj M.I. Bupropion is a nicotinic antagonist. Journal of Pharmacology and Experimental Therapeutics 2000, 295:321-327.
267. Sonksen P.H., Russell-Jones D., Jones R.H. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?. Hormone Research 1993, 40:68-79.
268. Spangler J.G. Smoking and hormone-related disorders. Primary Care 1999, 26:499-511.
269. Steptoe A., Ussher M. Smoking, cortisol and nicotine. International Journal of Psychophysiology 2006, 59:228-235.
270. Sterzik K., Strehler E., De Santo M., Trumpp N., Abt M., Rosenbusch B., Schneider A. Influence of smoking on fertility in women attending an in vitro fertilization program. Fertility and Sterility 1996, 65:810-814.
271. Sujkovic E., Mileusnic R., Fry J.P., Rose S.P. Temporal effects of dehydroepiandrosterone sulfate on memory formation in day-old chicks. Neuroscience 2007, 148:375-384.
272. Svartberg J., Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromso study. International Journal of Andrology 2007, 30:137-143.
273. Svartberg J., Midtby M., Bonaa K.H., Sundsfjord J., Joakimsen R.M., Jorde R. The associations of age, lifestyle factors and chronic disease with testosterone in men: The Tromso study. European Journal of Endocrinology 2003, 149:145-152.
274. Swanson L.W., Sawchenko P.E. Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annual Review of Neuroscience 1983, 6:269-324.
275. Tanko L.B., Christiansen C. An update on the antiestrogenic effect of smoking: A literature review with implications for researchers and practitioners. Menopause (New York) 2004, 11:104-109.
276. Tansavatdi K., McClain B., Herrington D.M. The effects of smoking on estradiol metabolism. Minerva Ginecologica 2004, 56:105-114.
277. Thaker G.K., Ross D.E., Buchanan R.W., Adami H.M., MedoffD.R. Smooth pursuit eye movements to extraretinal motion signals: Deficits in patients with schizophrenia. Psychiatry Research 1999, 88(3):209-219.
278. Thornton J., Kelly S.P., Harrison R.A., Edwards R. Cigarette smoking and thyroid eye disease: A systematic review. Eye (London) 2007, 21:1135-1145.
279. Tizabi Y., Rezvani A.H., Russell L.T., Tyler K.Y., Overstreet D.H. Depressive characteristics of FSL rats: Involvement of central nicotinic receptors. Pharmacology, Biochemistry, and Behavior 2000, 66:73-77.
280. Tonstad S. Use of sustained-release bupropion in specific patient populations for smoking cessation. Drugs 2002, 62(supplement 2):37-43.
281. Tritto T., Stitzel J.A., Marks M.J., Romm E., Collins A.C. Variability in response to nicotine in the LSxSS RI strains: Potential role of polymorphisms in alpha 4 and alpha 6 nicotinic receptor genes. Pharmacogenetics 2002, 12(3):197-208.
282. Tung C.S., GrenhoffJ., Svensson T.H. Nicotine counteracts midbrain dopamine cell dysfunction induced by prefrontal cortex inactivation. Acta Physiologica Scandinavica 1990, 138:427-428.
283. Utiger R.D. Effects of smoking on thyroid function. European Journal of Endocrinology 1998, 138:368-369.
284. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: Regulation by corticotropin-releasing factor. Alcoholism, Clinical and Experimental Research 2002, 26:1494-1501.
285. Valera S., Ballivet M., Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:9949-9953.
286. Valimaki M.J., Laitinen K.A., Tahtela R.K., Hirvonen E.J., Risteli J.P. The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: A prospective, controlled study. American Journal of Obstetrics and Gynecology 2003, 189:1213-1220.
287. Van Cauter E., Shapiro E.T., Tillil H., Polonsky K.S. Circadian modulation of glucose and insulin responses to meals: Relationship to cortisol rhythm. American Journal of Physiology 1992, 262:E467-E475.
288. Van Voorhis B.J., Dawson J.D., Stovall D.W., Sparks A.E., Syrop C.H. The effects of smoking on ovarian function and fertility during assisted reproduction cycles. Obstetrics and Gynecology 1996, 88:785-791.
289. Vestergaard P. Smoking and thyroid disorders - a meta-analysis. European Journal of endocrinology 2002, 146:153-161.
290. Vestergaard P., Rejnmark L., Weeke J., et al. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 2002, 12:69-75.
291. Vine M.F., Margolin B.H., Morrison H.I., Hulka B.S. Cigarette smoking and sperm density: A meta-analysis. Fertility and Sterility 1994, 61:35-43.
292. Weidenfeld J., BodoffM., Saphier D., Brenner T. Further studies on the stimulatory action of nicotine on adrenocortical function in the rat. Neuroendocrinology 1989, 50:132-138.
293. West R., Hajek P. What happens to anxiety levels on giving up smoking?. American Journal of Psychiatry 1997, 154:1589-1592.
294. WesthoffC., Gentile G., Lee J., Zacur H., Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. American Journal of Epidemiology 1996, 144:381-388.
295. Wilhelm K., Mitchell P., Slade T., Brownhill S., Andrews G. Prevalence and correlates of DSM-IV major depression in an Australian national survey. Journal of Affective Disorders 2003, 75:155-162.
296. Wilkins J.N., Carlson H.E., Van Vunakis H., Hill M.A., Gritz E., Jarvik M.E. Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 1982, 78:305-308.
297. Windham G.C., Elkin E.P., Swan S.H., Waller K.O., Fenster L. Cigarette smoking and effects on menstrual function. Obstetrics and Gynecology 1999, 93:59-65.
298. Winternitz W.W., Quillen D. Acute hormonal response to cigarette smoking. Journal of Clinical Pharmacology 1977, 17:389-397.
299. Wolf O.T., Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: Effects on cognition and emotion in animals and humans. Brain Research 1999, 30:264-288.
300. Wong P.K., Christie J.J., Wark J.D. The effects of smoking on bone health. Clinical Science (Lond) 2007, 113:233-241.
301. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Progress in Neurobiology 1991, 37:475-524.
302. Yeh J., Barbieri R.L. Twenty-four-hour urinary-free cortisol in premenopausal cigarette smokers and nonsmokers. Fertility and Sterility 1989, 52:1067-1069.
303. Yehuda R., Brand S.R., Golier J.A., Yang R.K. Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatrica Scandinavica 2006, 114:187-193.
304. Young A.H. Cortisol in mood disorders. Stress (Amsterdam) 2004, 7:205-208.
305. Young A.H., Gallagher P., Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. American Journal of Psychiatry 2002, 159:1237-1239.
306. Zhou F.M., Wilson C.J., Dani J.A. Cholinergic interneuron characteristics and nicotinic properties in the striatum. Journal of Neurobiology 2002, 53:590-605.
307. Zubenko G.S., Hughes H.B., Stiffler J.S., Zubenko W.N., Kaplan B.B. Genome survey for susceptibility loci for recurrent, early-onset major depression: Results at 10cM resolution. American Journal of Medical Genetics 2002, 114:413-422.